Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M V, Dhodapkar"'
Autor:
J. A. Zonder, J. Richter, N. Bumma, J. Brayer, J. E. Hoffman, W. I. Bensinger, K. L. Wu, L. Xu, D. Chokshi, A. Boyapati, D. Cronier, Y. Houvras, K. Rodriguez Lorenc, G. S. Kroog, M. V. Dhodapkar, S. Lentzsch, D. Cooper, S. Jagannath
Publikováno v:
HemaSphere, Vol 6, Pp 90-91 (2022)
Externí odkaz:
https://doaj.org/article/149cd676968b4008a614afbdf52a9b83
Autor:
M V Dhodapkar, H Desai, Nina Bhardwaj, Vincenzo Cerundolo, P R Dunbar, Mark Sapp, Joseph Krasovsky, Sean M. Donahoe, Ralph M. Steinman, Douglas F. Nixon, C Fossella
Publikováno v:
Scopus-Elsevier
Dendritic cells (DCs) are potent antigen-presenting cells that initiate protective T-cell immunity in mice. To study the immunogenicity of DCs in humans, we injected 9 healthy subjects subcutaneously with a control injection of autologous monocyte-de
Autor:
A D, Cohen, P, Zhou, Q, Xiao, M, Fleisher, N, Kalakonda, T, Akhurst, D A, Chitale, C, Moscowitz, M V, Dhodapkar, J, Teruya-Feldstein, D, Filippa, R L, Comenzo
Publikováno v:
British journal of haematology. 124(3)
Systemic AL amyloidosis (AL) is a disorder in which light chains form fibrillar deposits, leading to organ dysfunction and death. Rarely, AL has been associated with non-Hodgkin's lymphoma (NHL), although this association has not been well characteri
Autor:
M V, Dhodapkar, N, Bhardwaj
Publikováno v:
Journal of clinical immunology. 20(3)
Dendritic cells (DCs) are potent antigen-presenting cells specialized to initiate T-cell immunity. The development of methods to generate large numbers of DCs has facilitated their application for immunotherapy. Recent studies have demonstrated the s
Autor:
M V, Dhodapkar, J, Singh, J, Mehta, A, Fassas, K R, Desikan, M, Perlman, N C, Munshi, B, Barlogie
Publikováno v:
British journal of haematology. 103(2)
Two patients with progressive myeloma were treated with pamidronate disodium every 2-4 weeks. Pamidronate therapy resulted in a significant reduction of marrow plasmacytosis and plasma cell labelling index (PCLI), together with durable (or = 20 month
Publikováno v:
Blood. 91(8)
Multiple myeloma is characterized by an accumulation of malignant plasma cells in the bone marrow coupled with an altered balance of osteoclasts and osteoblasts, leading to lytic bone disease. Although some of the cytokines driving this process have
Publikováno v:
Cancer. 77(4)
Information regarding prognostic factors and survival in elderly women with metastatic breast cancer treated with tamoxifen is limited.The data from 4 prospective clinical trials were analyzed, including information on 396 postmenopausal women with a
Publikováno v:
Cancer. 75(1)
Data regarding the effects of estrogen replacement therapy (ERT) and its withdrawal in patients with breast cancer are limited.Four cases were observed involving estrogen replacement therapy withdrawal as management of metastatic breast cancer.Three
Publikováno v:
Cancer. 72(1)
The analysis of peripheral blood mononuclear cells for plasma cells and B-cell surface light chain ratios may provide additional insight on the pathogenesis of multiple myeloma and predict disease activity. The goals of this study were to correlate t